Come up with a name for your new list and we'll add to it:
Altimmune raised a round of funding on September 18, 2008. Investors include
National Institutes of Health.
Altimmune, formerly Vaxin, is an immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases.…